{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:07:55Z","timestamp":1784887675245,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["FWO 1S33521N"],"award-info":[{"award-number":["FWO 1S33521N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001240","name":"SpinalCure Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009550","name":"Hasselt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008191","name":"Wings for Life Privatstiftung f\u00fcr R\u00fcckenmarksforschung","doi-asserted-by":"publisher","award":["WFL-BE-20\/20"],"award-info":[{"award-number":["WFL-BE-20\/20"]}],"id":[{"id":"10.13039\/100008191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nbd.2026.107306","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:10:30Z","timestamp":1770077430000},"page":"107306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Spinal cord reactive-antibodies identified by serological antigen selection show prognostic value in traumatic spinal cord injury patients"],"prefix":"10.1016","volume":"220","author":[{"given":"Astrid","family":"Pues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vandormael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Vangansewinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Veeningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Vanherle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C.M.","family":"van Laake-Geelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin M.J.","family":"Cornips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Peuskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveleen","family":"Buelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Depreitere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Bamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Ruitenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Arevalo-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Garcia-Ovejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Grassner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orpheus","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Leister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fraussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107306_bb0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh","year":"2019","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.nbd.2026.107306_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.it.2010.06.006","article-title":"B cells and autoantibodies: complex roles in CNS injury","volume":"31","author":"Ankeny","year":"2010","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.nbd.2026.107306_bb0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1471-4159.2006.04147.x","article-title":"Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis","volume":"99","author":"Ankeny","year":"2006","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.nbd.2026.107306_bb0020","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1172\/JCI39780","article-title":"B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice","volume":"119","author":"Ankeny","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2026.107306_bb0025","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3389\/fimmu.2018.02365","article-title":"Elevated autoantibodies in subacute human spinal cord injury are naturally occurring antibodies","volume":"9","author":"Arevalo-Martin","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.nbd.2026.107306_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/acn3.318","article-title":"IVIg attenuates complement and improves spinal cord injury outcomes in mice","volume":"3","author":"Brennan","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2026.107306_bb0035","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.apmr.2007.08.004","article-title":"Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury","volume":"88","author":"Davies","year":"2007","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"3","key":"10.1016\/j.nbd.2026.107306_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/1673-5374.202933","article-title":"The translational importance of establishing biomarkers of human spinal cord injury","volume":"12","author":"Elizei","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"6","key":"10.1016\/j.nbd.2026.107306_bb0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/08977150260139129","article-title":"Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury","volume":"19","author":"Hayes","year":"2002","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.nbd.2026.107306_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/WNR.0000000000000502","article-title":"Identification of autoantibodies to glial fibrillary acidic protein in spinal cord injury patients","volume":"27","author":"Hergenroeder","year":"2016","journal-title":"NeuroReport"},{"issue":"21","key":"10.1016\/j.nbd.2026.107306_bb0055","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1089\/neu.2018.5675","article-title":"Increased levels of circulating glial fibrillary acidic protein and Collapsin response mediator protein-2 autoantibodies in the acute stage of spinal cord injury predict the subsequent development of neuropathic pain","volume":"35","author":"Hergenroeder","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.nbd.2026.107306_bb0060","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1093\/brain\/awad092","article-title":"The spinal cord injury-induced immune deficiency syndrome: results of the SCIentinel study","volume":"146","author":"Kopp","year":"2023","journal-title":"Brain J. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2026.107306_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/neu.2013.2982","article-title":"Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis?","volume":"31","author":"Krishna","year":"2014","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.nbd.2026.107306_bb0070","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000931","article-title":"Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE","volume":"8","author":"Laurent","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.nbd.2026.107306_bb0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fmed.2019.00224","article-title":"Raising to the challenge: building a federated biobank to accelerate translational research\u2014the university biobank Limburg","volume":"6","author":"Linsen","year":"2019","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.nbd.2026.107306_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.expneurol.2007.05.019","article-title":"Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation","volume":"207","author":"Lucin","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107306_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1067833","article-title":"Novel maternal autoantibodies in autism spectrum disorder: implications for screening and diagnosis","volume":"17","author":"Maz\u00f3n-Cabrera","year":"2023","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2026.107306_bb0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sc.1983.48","article-title":"Systemic humoral factors participating in the course of spinal cord injury","volume":"21","author":"Mizrachi","year":"1983","journal-title":"Spinal Cord"},{"key":"10.1016\/j.nbd.2026.107306_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jns.2017.05.045","article-title":"Association between interleukin-32 polymorphism and multiple sclerosis","volume":"379","author":"Morsaljahan","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.nbd.2026.107306_bb0100","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00415-011-6036-7","article-title":"Elevated serum level of interleukin-32\u03b1 in the patients with myasthenia gravis","volume":"258","author":"Na","year":"2011","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107306_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12974-017-0894-6","article-title":"Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury, drive secondary injury by activating complement","volume":"14","author":"Narang","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.nbd.2026.107306_bb0110","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/1742-2094-9-224","article-title":"Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury","volume":"9","author":"Nguyen","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.nbd.2026.107306_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2567.2009.03119.x","article-title":"Antibodies to wounded tissue enhance cutaneous wound healing","volume":"128","author":"Nishio","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.nbd.2026.107306_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.05.007","article-title":"The spleen as a neuroimmune interface after spinal cord injury","volume":"321","author":"Noble","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.nbd.2026.107306_bb0125","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.4049\/jimmunol.1101934","article-title":"Chronic spinal cord injury impairs primary antibody responses but spares existing humoral immunity in mice","volume":"188","author":"Oropallo","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107306_bb0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12974-016-0713-5","article-title":"Antibody profiling identifies novel antigenic targets in spinal cord injury patients","volume":"13","author":"Palmers","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.nbd.2026.107306_bb0135","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.41427","article-title":"Antibodies against three novel peptides in early axial Spondyloarthritis patients from two independent cohorts","volume":"72","author":"Quaden","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.nbd.2026.107306_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuroscience.2014.08.045","article-title":"Autoantibodies in traumatic brain injury and central nervous system trauma","volume":"281","author":"Raad","year":"2014","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.nbd.2026.107306_bb0145","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1007\/s12035-023-03333-8","article-title":"Suppression of microglial ERO1a alleviates inflammation and enhances the efficacy of rehabilitative training after ischemic stroke","volume":"60","author":"Ren","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.nbd.2026.107306_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46292\/sci2702-1","article-title":"International standards for neurological classification of spinal cord injury","volume":"27","author":"Rupp","year":"2021","journal-title":"Top. Spinal Cord Inj. Rehabil."},{"key":"10.1016\/j.nbd.2026.107306_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2022.03.009","article-title":"The human anti-ganglioside GM1 autoantibody response following traumatic and surgical central nervous system insults","author":"Schneider","year":"2022","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2026.107306_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.expneurol.2014.04.023","article-title":"The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury","volume":"258","author":"Schwab","year":"2014","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2026.107306_bb0165","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200099","article-title":"Lesional antibody synthesis and complement deposition associate with De novo Antineuronal antibody synthesis after spinal cord injury","volume":"10","author":"Schwab","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.nbd.2026.107306_bb0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12883-024-03703-2","article-title":"The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis","volume":"24","author":"Shi","year":"2024","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2026.107306_bb0175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/10790268.2020.1854550","article-title":"Elevated levels of IgA and IgG2 in individuals with chronic spinal cord injury","volume":"45","author":"Shnawa","year":"2022","journal-title":"J. Spinal Cord Med."},{"key":"10.1016\/j.nbd.2026.107306_bb0180","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2008.0760","article-title":"Conversion in ASIA impairment scale during the first year after traumatic spinal cord injury","author":"Spiess","year":"2009","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.nbd.2026.107306_bb0185","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41393-020-0436-4","article-title":"Neurological recovery after traumatic spinal cord injury: what is meaningful? A patients\u2019 and physicians\u2019 perspective","volume":"58","author":"ter Wengel","year":"2020","journal-title":"Spinal Cord"},{"issue":"6340","key":"10.1016\/j.nbd.2026.107306_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"issue":"6220","key":"10.1016\/j.nbd.2026.107306_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nbd.2026.107306_bb0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12026-016-8839-1","article-title":"cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis","volume":"65","author":"Vandormael","year":"2017","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.nbd.2026.107306_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004743","article-title":"Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis","volume":"10","author":"Vandormael","year":"2024","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.nbd.2026.107306_bb0210","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201942RR","article-title":"Therapeutic administration of mouse mast cell protease 6 improves functional recovery after traumatic spinal cord injury in mice by promoting remyelination and reducing glial scar formation","volume":"37","author":"Vangansewinkel","year":"2023","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.nbd.2026.107306_bb0215","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10875-012-9837-2","article-title":"Increased plasma interleukin-32 expression in patients with neuromyelitis optica","volume":"33","author":"Wang","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.nbd.2026.107306_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbi.2022.12.018","article-title":"Intravenous immunoglobulin (IVIG) promotes brain repair and improves cognitive outcomes after traumatic brain injury in a Fc\u03b3RIIB receptor-dependent manner","volume":"109","author":"Willis","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.nbd.2026.107306_bb0225","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s12035-016-9757-x","article-title":"The next generation of biomarker research in spinal cord injury","volume":"54","author":"Ydens","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.nbd.2026.107306_bb0230","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00586-011-2060-7","article-title":"Autoreactivity against myelin basic protein in patients with chronic paraplegia","volume":"21","author":"Zajar\u00edas-Fainsod","year":"2012","journal-title":"Eur. Spine J."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:02:08Z","timestamp":1778792528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"alternative-id":["S0969996126000501"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107306","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal cord reactive-antibodies identified by serological antigen selection show prognostic value in traumatic spinal cord injury patients","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107306"}}